NRx Pharmaceuticals Inc.

NASDAQ: NRXP · Real-Time Price · USD
2.80
-0.09 (-3.11%)
At close: Aug 18, 2025, 3:06 PM

NRx Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-25.13M -30.15M -39.75M -93.06M
Depreciation & Amortization
5K 5K 4K 2K
Stock-Based Compensation
486K 387K 3.63M 7.79M
Other Working Capital
10.51M 2.51M 2.31M -5.71M
Other Non-Cash Items
8.71M 2.94M -4.33M 54.28M
Deferred Income Tax
n/a n/a n/a -1.81M
Change in Working Capital
5.29M 5.16M 699K -4.9M
Operating Cash Flow
-10.64M -21.66M -39.76M -37.7M
Capital Expenditures
n/a -3K -10K -7K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a -3K -10K -7K
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 7K
Investing Cash Flow
n/a -3K -10K -7K
Debt Repayment
-1.5M -3.09M 9.5M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.07M n/a 10K 26.47M
Financial Cash Flow
7.49M 6.2M 32.21M 63.46M
Net Cash Flow
-3.15M -15.46M -7.55M 25.75M
Free Cash Flow
-10.64M -21.66M -39.77M -37.71M